The five-year initiative aims to collect and disseminate genomic data on 1 million people with Alzheimer's disease or who are at risk for the condition.
The bipartisan bill is backed by more than 250 organizations, but ACMG remains opposed, arguing that ordering tests is part of the practice of medicine.
A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.
